RECITALS --------Stock Option Grant • November 14th, 2003 • Strategic Diagnostics Inc/De/ • Miscellaneous chemical products • Delaware
STOCK OPTION GRANTStock Option Grant • March 7th, 2023 • Edgemode, Inc. • Services-home health care services • Nevada
This STOCK OPTION GRANT, dated as of March 3, 2023 is delivered by EdgeMode, Inc., a Nevada corporation (the “Company”) to Simon Wajcenberg (the “Employee”).
STOCK OPTION GRANTStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Reference is hereby made to (i) the Stock Option Plan of Lightlake Therapeutics Inc. (the “Company”) effective December 15, 2010 (the “Stock Option Plan”), and (ii) the Employment Agreement dated August 6, 2010, between the Company and Michael Sinclair, as amended on December 31, 2012, and further amended on December 31, 2013 (as amended, restated, or otherwise modified from time to time, the “Letter”). Capitalized terms utilized herein shall have the meanings ascribed to them in the Stock Option Plan unless otherwise defined herein or in the Letter.
STOCK OPTION GRANTStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
As per the Agreement dated January 22, 2013, as amended, between Lightlake Therapeutics Inc. (the “Company”) and you, you have been granted options (the “Options”) to purchase common stock (the “Common Stock”) of the Company (with each share of Common Stock of the Company, a “Share”) as follows:
STOCK OPTION GRANTStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Reference is hereby made to (i) the Stock Option Plan of Lightlake Therapeutics Inc. (the “Company”) effective December 15, 2010 (the “Stock Option Plan”), and (ii) the Director Agreement dated December 31, 2012, between the Company and Geoffrey Wolf (as amended, restated, or otherwise modified from time to time, the “Letter”). Capitalized terms utilized herein shall have the meanings ascribed to them in the Stock Option Plan unless otherwise defined herein or in the Letter.
ACLARIS THERAPEUTICS, INC. STOCK OPTION GRANTStock Option Grant • August 17th, 2015 • Aclaris Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Agreement (this “Agreement”) dated as of [ ] and effective as of [ ] (the “Grant Date”), between Aclaris Therapeutics, Inc., a Delaware corporation (the “Company”), and [ ] (“Grantee”), an employee of the Company. Capitalized terms used but not defined herein shall have the meaning set forth in the Plan (as defined below).
AMENDED STOCK OPTION GRANTStock Option Grant • November 4th, 2008 • Interline Resources Corp • Crude petroleum & natural gas • Utah
Agreement dated as of the 15th day of day of October, 2008 by and between Westcoast Lending Group, Inc., a Nevada corporation, or its successors or assigns, whose address is for purposes of this Agreement, c/o Private Capital Group, 486 W 50 N American Fork, UT 84003 ("Optionee") and Interline Resources Corporation, a Utah corporation, whose address is 160 West Canyon Crest, Alpine, Utah 84404 (the "Corporation").
FIRST AMENDMENT TO STOCK OPTION GRANTStock Option Grant • March 8th, 2018 • Assembly Biosciences, Inc. • Pharmaceutical preparations
THIS FIRST AMENDMENT TO STOCK OPTION Grant (the “Amendment”) is dated effective as of November 1, 2017 and is entered into by and among Assembly Biosciences, Inc., a Delaware corporation (“Company”) and Miguel S. Barbosa, Ph.D. ("Optionee"). Capitalized terms used in this Amendment that are not defined shall have the meaning assigned to such term in the that certain Stock Option Grant No. 2016-60 dated September 26, 2016 (the “Stock Option”). This Amendment is being entered into by the parties pursuant to that certain Transition and Resignation Agreement dated October 30, 2017 (the “Resignation Agreement”) and is Exhibit B to such Resignation Agreement.
GENERAL MILLS, INC. STOCK OPTION GRANT AGREEMENTStock Option Grant • June 29th, 2018 • General Mills Inc • Grain mill products
THIS GRANT dated , is made by GENERAL MILLS, INC., (the “Company”), and made to the person named above (the “Optionee” or referred to as “I”, “you” or “my”). The Grant is made under the General Mills, Inc. 2017 Stock Compensation Plan (“Plan”), and is subject to the terms and conditions contained in the Plan document, as amended, and this Grant document.
RECITALSStock Option Grant • March 31st, 2005 • Cash Systems Inc • Finance services • Minnesota
Stratasys, Inc. Board Of Directors Stock Option Grant Under The Stratasys, Inc. _____ Long Term Performance and Incentive Plan (the “_____ Plan”) As adopted by the Shareholders on __________ This Option is a grant of a Non-Qualified Stock Option as...Stock Option Grant • March 11th, 2009 • Stratasys Inc • Computer peripheral equipment, nec • Delaware
AGREEMENT made as of the ___ day of _____, ____ by and between Stratasys, Inc., a Delaware corporation having its principal place of business at 14950 Martin Drive, Eden Prairie, Minnesota 55344 ("Grantor"), and «BOD MBR NAME» (“Optionee”) residing at «HOMEADDRESS», «CITYSTATEZIP».
STOCK OPTION GRANTStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Reference is hereby made to (i) the Stock Option Plan of Lightlake Therapeutics Inc. (the “Company”) effective December 15, 2010 (the “Stock Option Plan”), and (ii) the Employment Agreement dated August 6, 2010, between the Company and Michael Sinclair, as amended on December 31, 2012, and further amended on December 31, 2013 (as amended, restated, or otherwise modified from time to time, the “Letter”). Capitalized terms utilized herein shall have the meanings ascribed to them in the Stock Option Plan unless otherwise defined herein or in the Letter.
SIGNIFY HEALTH, INC. AMENDED AND RESTATED NOTICE OF SUBSTITUTE NON-STATUTORY STOCK OPTION GRANTStock Option Grant • May 5th, 2022 • Signify Health, Inc. • Services-home health care services • Delaware
The Signify Stock Options were granted in connection with the initial public offering of Signify Class A Shares (the “Signify IPO”) and the entry into that certain Agreement and Plan of Merger, dated as of February 12, 2021, by and among the Company, New Remedy Corp., a Delaware corporation (“New Remedy”) and Merger Sub 2, Inc., a Delaware corporation (the “New Remedy Merger Agreement”), pursuant to which each outstanding stock option to purchase shares of Class A common stock, par value $0.001, of New Remedy (“New Remedy Class A Shares”) previously granted to the Participant under the terms of the New Remedy Corp. Amended and Restated 2019 Equity Incentive Plan (the “New Remedy Plan”) was assumed by the Company and converted into a Signify Stock Option, and is subject to the terms set forth in this Notice and the Agreement.
INTUIT INC. DIRECTORS NONQUALIFIED INITIAL STOCK OPTION GRANTStock Option Grant • January 24th, 2002 • Intuit Inc • Services-prepackaged software
This Stock Option Grant (this “Grant”) is made and entered into as of the date of grant set forth below (the “Date of Grant”) by and between Intuit Inc., a Delaware corporation (the “Company”), and the Optionee named below (“Optionee”).
Stock Option GrantStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Pursuant to the Employment Agreement between Opiant Pharmaceuticals, Inc. (the “Company”) and you effective February 6, 2017 (the “Employment Agreement”), the Company has granted you options (the “Options”) to purchase common stock of the Company (the “Common Stock”) (with each share of Common Stock, a “Share”) as follows:
VERTEX PHARMACEUTICALS INCORPORATEDStock Option Grant • February 19th, 2010 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations
This Agreement sets forth the terms and conditions of an Option granted pursuant to the provisions of the 2006 Stock and Option Plan (the “Plan”) of Vertex Pharmaceuticals Incorporated (the “Company”) to the Participant whose name appears below, covering the number of Shares of Common Stock of the Company set forth below, pursuant to the provisions of the Plan and on the following express terms and conditions. Capitalized terms not otherwise defined herein shall have the same meanings as set forth in the Plan.
STOCK OPTION GRANTStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
As per the Letter Agreement dated November 12, 2014 between Lightlake Therapeutics Inc. (the “Company”) and you, you have been granted options (the “Options”) to purchase common stock (the “Common Stock”) of the Company (with each share of Common Stock of the Company, a “Share”) as follows:
VERSANT CORPORATION DIRECTORS NONQUALIFIED INITIAL STOCK OPTION GRANTStock Option Grant • December 22nd, 2005 • Versant Corp • Services-prepackaged software
This Stock Option Grant (this “Grant”) is made and entered into as of the date of grant set forth below (the “Date of Grant”) by and between Versant Corporation, a California corporation (the “Company”), and the Optionee named below (“Optionee”).
STOCK OPTION GRANTStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Reference is hereby made to (i) the Stock Option Plan of Lightlake Therapeutics Inc. (the “Company”) effective December 15, 2010 (the “Stock Option Plan”), and (ii) the Senior Advisor Agreement dated January 22, 2013, between the Company and Brad Miles (as amended, restated, or otherwise modified from time to time, the “Letter”). Capitalized terms utilized herein shall have the meanings ascribed to them in the Stock Option Plan unless otherwise defined herein.
1 EXHIBIT 10.29 INITIAL GRANT ALLERGY SUPERSTORE.COM, INC. 1999 DIRECTORS STOCK OPTION PLAN DIRECTORS NONQUALIFIED INITIAL STOCK OPTION GRANT This Stock Option Grant (this "GRANT") is made and entered into as of the Date of Grant set forth below (the...Stock Option Grant • May 17th, 1999 • Bioshield Technologies Inc • Specialty cleaning, polishing and sanitation preparations
STOCK OPTION GRANTStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
As per the Letter Agreement dated November 12, 2014 between Lightlake Therapeutics Inc. (the “Company”) and you, you have been granted options (the “Options”) to purchase common stock (the “Common Stock”) of the Company (with each share of Common Stock of the Company, a “Share”) as follows:
Spherix Incorporated STOCK OPTION GRANTStock Option Grant • November 15th, 2004 • Spherix Inc • Services-engineering, accounting, research, management
AGREEMENT made between Spherix Incorporated, a corporation of the State of Delaware, hereinafter referred to as SPHERIX and hereinafter referred to as the OPTIONEE.
STOCK OPTION GRANTStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Reference is hereby made to (i) the Stock Option Plan of Lightlake Therapeutics Inc. (the “Company”) effective December 15, 2010 (the “Stock Option Plan”), and (ii) the Director Agreement dated December 31, 2012, between the Company and Geoffrey Wolf (as amended, restated, or otherwise modified from time to time, the “Letter”). Capitalized terms utilized herein shall have the meanings ascribed to them in the Stock Option Plan unless otherwise defined herein.
